Haleon PLC Holding(s) in Company (6001Z)
May 16 2023 - 8:00AM
UK Regulatory
TIDMHLN
RNS Number : 6001Z
Haleon PLC
16 May 2023
16 May 2023
HALEON PLC
("Haleon" or "the Company")
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BMX86B70
Issuer Name
Haleon plc
UK or Non-UK Issuer
UK
2. Reason for Notification
An acquisition or disposal of voting rights
3. Details of person subject to the notification obligation
Name
Glaxo Group Limited
City of registered office (if applicable)
Brentford
Country of registered office (if applicable)
United Kingdom
Name City of registered office Country of registered office
GlaxoSmithKline Holdings Limited Brentford England
=========================== ==============================
GlaxoSmithKline Finance plc Brentford England
=========================== ==============================
4. Details of the shareholder
Name City of registered office Country of registered office
Vidacos Nominees Limited London England
=========================== ==============================
5. Date on which the threshold was crossed or reached
12-May-2023
6. Date on which Issuer notified
15-May-2023
7. Total positions of person(s) subject to the notification
obligation
% of voting rights % of voting rights Total of both in % Total number of
attached to shares through financial (8.A + 8.B) voting rights held
(total of 8.A) instruments (total in issuer
of 8.B 1 + 8.B 2)
Resulting situation
on the date on
which threshold
was crossed or
reached 2.850000 0.000000 2.850000 262727073
====================== ====================== ====================== ======================
Position of
previous
notification (if
applicable) 5.440000 0.000000 5.440000
====================== ====================== ====================== ======================
8. Notified details of the resulting situation on the date on
which the threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares Number of direct Number of indirect % of direct voting % of indirect voting
ISIN code(if possible) voting rights (DTR5.1) voting rights rights (DTR5.1) rights (DTR5.2.1)
(DTR5.2.1)
GB00BMX86B70 262727073 2.850000
====================== ====================== ====================== ======================
Sub Total 8.A 262727073 2.850000%
============================================== ==============================================
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial Expiration date Exercise/conversion period Number of voting rights % of voting rights
instrument that may be acquired if
the instrument is
exercised/converted
Sub Total 8.B1
=========================================== ========================= ==================
8B2. Financial Instruments with similar economic effect
according to (DTR5.3.1R.(1) (b))
Type of financial Expiration date Exercise/conversion Physical or cash Number of voting % of voting rights
instrument period settlement rights
Sub Total 8.B2
========================================================= =================== ==================
9. Information in relation to the person subject to the
notification obligation
2. Full chain of controlled undertakings through which the
voting rights and/or the financial instruments are effectively held
starting with the ultimate controlling natural person or legal
entities (please add additional rows as necessary)
Ultimate controlling Name of controlled % of voting rights if % of voting rights Total of both if it
person undertaking it equals or is through financial equals or is higher
higher than the instruments if it than the notifiable
notifiable threshold equals or is higher threshold
than the notifiable
threshold
GSK plc 2.850000 2.850000%
===================== ===================== ======================
GlaxoSmithKline
GSK plc Holdings Limited 2.850000 2.850000%
======================= ===================== ===================== ======================
GlaxoSmithKline
GSK plc Finance plc 2.850000 2.850000%
======================= ===================== ===================== ======================
GSK plc Glaxo Group Limited 2.850000 2.850000%
======================= ===================== ===================== ======================
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
GSK plc is making this notification on behalf of Glaxo Group
Limited, GlaxoSmithKline Finance plc and GlaxoSmithKline Holdings
Limited.
This notification relates to the sale by Glaxo Group Limited (a
wholly-owned subsidiary of GSK plc and the holder of other external
minority interests of the GSK group) of a portion of its interest
in Haleon plc. A separate notification has also been submitted
today by GSK plc in respect of its own notification obligation.
Glaxo Group Limited holds its shares in Haleon plc via a
custodian, Vidacos Nominees Limited (as detailed in section 4
above), which holds the legal title to those shares on Glaxo Group
Limited's behalf pursuant to a custody arrangement.
12. Date of Completion
15-May-2023
13. Place Of Completion
London, England
Amanda Mellor, Company Secretary
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLUNRAROOUVAAR
(END) Dow Jones Newswires
May 16, 2023 09:00 ET (13:00 GMT)
Haleon (LSE:HLN)
Historical Stock Chart
From Apr 2024 to May 2024
Haleon (LSE:HLN)
Historical Stock Chart
From May 2023 to May 2024